BMI1 and colorectal cancer: Basically, the mechanism involved in PP2A‐mediated BMI1 ubiquitination and proteasomal degradation associated with colorectal cancer; hence, HTfNPs exerted notable therapeutic effects as an anticancer therapeutic to target colorectal cancer.